Founded in 2005. Integrated BioTherapeutics (IBT) is a biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging diseases.

Rockville, MD
Joined May 2021
M. Javad Aman, Ph.D., President, and CEO of Integrated BioTherapeutics, discusses his Montgomery County-based company's R&D mission to develop vaccines and therapies to combat emerging infectious diseases. For full video visit: ibtbioservices.com/
2
"Here we report the development of pan-ebolavirus and pan-filovirus antibodies generated by repeated immunization of mice with filovirus glycoproteins engineered to drive the B cell responses toward conserved epitopes." pubmed.ncbi.nlm.nih.gov/2646…
"The severe death toll caused by the recent outbreak of Ebola virus disease reinforces the importance of developing ebolavirus prevention and treatment strategies." #researchanddevelopment #vaccinedevelopment #biotechnology #vaccine #ebola #prevention integratedbiotherapeutics.co…
To the backbone of our future, Happy Parents Day from IBT
Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques #researchanddevelopment #research #vaccinedevelopment #biotechnology #VaccineRollOutSA integratedbiotherapeutics.co…
Check this out! IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Staphylococcus aureus #researchanddevelopment #research #vaccinedevelopment #biotechnology #vaccine integratedbiotherapeutics.co…
Check out our publication: Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody integratedbiotherapeutics.co…
IBT works diligently to help control infectious diseases through our antiviral and antibacterial research programs. #antiviral #antibacterial #pipeline #infectiousdiseases Take a look at our technology platforms and pipelines: integratedbiotherapeutics.co…
Our team has extensive experience in molecular and enzymatic assays, and immunoassays as single- and multiplexed platforms. Visit the IBT Bioservices website to learn more. #flowcytometry #assaydevelopment #proteinpurification lnkd.in/dRhk5HJ
Happy Juneteenth from Integrated BioTherapeutics
IBT Receives Phase I SBIR grant from NIAID for development of Novel ISTAb therapeutics for Staph aureus #NIH #grant #development #therapeutics Full view here: integratedbiotherapeutics.co…
Integrated Biotherapeutics retweeted
Let’s come together this June to celebrate the progress that has been made to promote health equity for the LGBTQ+ community and reflect on the work ahead. hhs.gov/about/news/2021/05/1… #Pride #PrideMonth
3
22
1
43
IBT Receives Phase I/II Fast Track SBIR grant from NIAID for development of broadly protective monoclonal antibodies against Influenza Virus (INFV) #NIAID #development #influenza #virus Read the full story: integratedbiotherapeutics.co…
1
IBT Receives Phase I SBIR grant from NIAID for development of neutralizing monoclonal antibodies against Marburg Virus #development #marburg #grant #NIAID Full read here: integratedbiotherapeutics.co…
IBT Receives Phase II STTR grant from NIAID for development of Novel ISTAb therapeutics for B. anthracis Read more here: integratedbiotherapeutics.co…
Happy Monday everyone, it's a great day to save lives! #biotherapeutics #research #RandD
CARB-X funds Integrated BioTherapeutics to expand the development of its staphylococcus aureus vaccine to facilitate use in the developing world #vaccine #research #development #innovative Read more here: integratedbiotherapeutics.co…
1
Novo Holdings REPAIR Impact Fund Invests USD 12 million in Mutabilis and IBT Vaccines and provides a strategic update! View the full article here: integratedbiotherapeutics.co…
Recent clinical successes of monoclonal antibodies (mAbs) in therapy for viral infections demonstrate that mAbs offer a solution for these emerging biothreats. #immunotherapy #antibodies #researchanddevelopment integratedbiotherapeutics.co…